Back to search results

Hyperbaric Oxygen Treatment for Necrotizing Fasciitis

This study is looking into whether hyperbaric oxygen treatment (a procedure where you breathe pure oxygen in a special pressurized room) can help people with necrotizing fasciitis or necrotizing soft tissue infections. These are serious infections that spread quickly. Researchers want to see if this treatment can improve how well people recover and reduce the number of deaths, compared to standard care. You could be eligible if you are 18 years or older and have a documented necrotizing infection. The main goal is to see if hyperbaric oxygen improves survival at 6 months after treatment. The current status of this study is unclear.

Study design
This is an interventional study planning to enroll 160 participants. It will compare hyperbaric oxygen treatment to standard care.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after the procedure to measure mortality improvement.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07170020

Hyperbaric Oxygen Treatment for Necrotizing Fasciitis and Necrotizing Soft Tissue Infections

Not Yet Recruiting
NAAges 18+InterventionalTreatment
Corewell Health West
~160 participants
Updated 2025-09-12 on ClinicalTrials.gov
What's tested:Hyperbaric Oxygen Therapy

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Mortality improvement
Measured over 6 months post procedure

Conditions

Necrotizing Fascitis

Explore related trials

Necrotizing FasciitisNecrotizing soft tissue infection

Where it's being run

1 sites across 1 states
Michigan1

Who to contact

Kendra Selby
[email protected]
616-486-0281
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Age: 18 years old
Patients with documented necrotizing fasciitis or necrotizing soft tissue infection as assessed during initial bedside evaluation, in conjunction with available laboratory values, imaging showing gas in soft tissues consitent with necrotizing infection, or surgical debridement of necrosis of fascia, muscle, and variable levels of soft tissue involvement
Patient or advocate is able to sign consent

Exclusion

Pediatric patients
Pregnant patients
Patients deemed unlikely to survive or unable to go to surgical debridement

What this trial measures

  • Mortality improvement6 months post procedure

    To evaluate if the addition of hyperbaric oxygen improves mortality in patients with necrotizing fasciitis and necrotizing soft tissue infections.